Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619528 · ClinicalTrials.gov registry record · NA
HLA-Identical Sibling Renal Transplant Tolerance
A NA study of Kidney Transplantation and Immunosuppression, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT00619528 is a NA study of Kidney Transplantation and Immunosuppression that has completed, run by Northwestern University. The registered enrollment target is 88 participants, below the 265-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00619528, a NA study of Kidney Transplantation and Immunosuppression, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to attempt to eliminate the necessity of immunosuppressive therapy for HLA-identical sibling Kidney Transplants, examine cellular chimerism of donor hematopoietic stem cell (DHSC) lineages for pairs to demonstrate immunologic unresponsiveness, and to investigate the safety and efficacy of the treatment regimen including withdrawal of immunosuppression after one year post-transplant for those recipients having received DHSC infusions.
Conditions Studied
Interventions
- BIOLOGICAL Infusion of Donor Hematopoietic Stem Cells and Campath-1H
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2008-01 |
| Est. Completion | 2023-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00619528
The ClinicalTrials.gov registry entry for NCT00619528 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 265-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (67% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Kidney Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Infusion of Donor Hematopoietic Stem Cells and Campath-1H is the first listed.
NCT00619528 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00619528 about?
NCT00619528 is a clinical study titled "HLA-Identical Sibling Renal Transplant Tolerance". The purpose of this study is to attempt to eliminate the necessity of immunosuppressive therapy for HLA-identical sibling Kidney Transplants, examine cellular chimerism of donor hematopoietic stem cell (DHSC) lineages for pairs to demonstrate immunologic unresponsiveness, and to investigate the safe...
What is the current status of trial NCT00619528?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2008-01. Estimated completion is 2023-09.
What conditions does trial NCT00619528 study?
This clinical trial studies the following conditions: Kidney Transplantation, Immunosuppression, Graft Rejection.
What interventions are being tested in trial NCT00619528?
The interventions under investigation include: Infusion of Donor Hematopoietic Stem Cells and Campath-1H (BIOLOGICAL).
Who is sponsoring clinical trial NCT00619528?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00619528 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
-
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
RECRUITING · NA
-
APOL1 Genetic Testing Program for Living Donors
ACTIVE NOT RECRUITING · NA
-
Watermelon/UBIQuinone Study
ACTIVE NOT RECRUITING · NA
-
Vitamin D Replacement After Kidney Transplant
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.